A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Chen, Christine
Paul, Harminder [1 ]
Xu, Wei
Kukreti, Vishal [1 ]
Trudel, Suzanne [1 ]
Wei, Ellen [1 ]
Li, Zhi Hua [1 ]
Brandwein, Joseph [1 ]
Pantoja, Mariela [1 ]
Leung-Hagensteijn, Chungyee [1 ]
机构：
[1] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [11] Preliminary Results From a Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide In Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
    Flinn, Ian W.
    Berdeja, Jesus G.
    Waselenko, Jamie K.
    Cooper, R. Seth
    Bi, Jia
    Shih, Kent
    Doss, Habib H.
    Dickson, Natalie
    Thompson, Dana S.
    Burris, Howard A., III
    Hainsworth, John D.
    BLOOD, 2010, 116 (21) : 1022 - 1022
  • [12] Single-Agent Lenalidomide in the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Chen, Christine I.
    Bergsagel, P. Leif
    Paul, Harminder
    Xu, Wei
    Lau, Anthea
    Dave, Nimisha
    Kukreti, Vishal
    Wei, Ellen
    Leung-Hagesteijn, Chungyee
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Johnston, James
    Gibson, Spencer
    Hernandez, Tiffany
    Spaner, David
    Trudel, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1175 - 1181
  • [13] Phase II Trial of Pulse Dosed Lenalidomide In Previously Treated Chronic Lymphocytic Leukemia
    Aue, Georg
    Soto, Susan
    Valdez, Janet
    Arthur, Diane C.
    Tian, Xin
    Wiestner, Adrian
    BLOOD, 2010, 116 (21) : 595 - 595
  • [14] Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia
    Byrd, John C.
    Flynn, Joseph M.
    Kipps, Thomas J.
    Boxer, Michael
    Kolibaba, Kathryn S.
    Carlile, David J.
    Fingerle-Rowson, Guenter
    Tyson, Nicola
    Hirata, Jamie
    Sharman, Jeff P.
    BLOOD, 2016, 127 (01) : 79 - 86
  • [15] Phase II trial of the combination of ofatumumab and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)
    Falchi, Lorenzo
    Keating, Michael J.
    Badoux, Xavier C.
    Wierda, William G.
    O'Brien, Susan Mary
    Smith, Susan C.
    Wen, Sijin
    Kantarjian, Hagop
    Ferrajoli, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [16] Lenalidomide added to bendamustine-rituximab for untreated chronic lymphocytic leukemia (CLL): A phase 1 study.
    Abramson, Jeremy S.
    Davids, Matthew Steven
    Werner, Lillian
    Fisher, David Christopher
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna S.
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [17] Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
    Alexander Egle
    Michael Steurer
    Thomas Melchardt
    Lukas Weiss
    Franz Josef Gassner
    Nadja Zaborsky
    Roland Geisberger
    Kemal Catakovic
    Tanja Nicole Hartmann
    Lisa Pleyer
    Daniela Voskova
    Josef Thaler
    Alois Lang
    Michael Girschikofsky
    Andreas Petzer
    Richard Greil
    Annals of Hematology, 2018, 97 : 1825 - 1839
  • [18] Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
    Egle, Alexander
    Steurer, Michael
    Melchardt, Thomas
    Weiss, Lukas
    Gassner, Franz Josef
    Zaborsky, Nadja
    Geisberger, Roland
    Catakovic, Kemal
    Hartmann, Tanja Nicole
    Pleyer, Lisa
    Voskova, Daniela
    Thaler, Josef
    Lang, Alois
    Girschikofsky, Michael
    Petzer, Andreas
    Greil, Richard
    ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1825 - 1839
  • [19] Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)
    Shanafelt, Tait D.
    Ramsay, Alan G.
    Zent, Clive S.
    Leis, Jose F.
    Tun, Han W.
    Call, Timothy G.
    LaPlant, Betsy
    Bowen, Deborah
    Pettinger, Adam
    Jelinek, Diane F.
    Hanson, Curtis A.
    Kay, Neil E.
    BLOOD, 2013, 121 (20) : 4137 - 4141
  • [20] A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    William, Basem M.
    Brillhart, Kaylee
    Afable, Manuel
    Bakalarz, Kristen
    Cooper, Brenda
    Lazarus, Hillard M.
    Gerson, Stanton L.
    Creger, Richard
    Nagabhushanam, Kalyanam
    Grote, James
    Fu, Pingfu
    Kunati, Sandeep
    Yang, Shuming
    Xu, Yan
    Woost, Philip
    Jacobberger, James
    de Lima, Marcos
    Caimi, Paolo
    BLOOD, 2018, 132
12345